|
[1] Chinese Medical Association Liver Diseases Branch Drug-induced hepatology group. Guidelines for the diagnosis and treatment of drug-induced liver injury[J]. J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
|
|
[2] ZHANG ST, WAN GJ, LI L. Research advances in the mechanism of drug-induced liver injury[J]. Pharm Care Res, 2017, 17 (1) :39-42. (in Chinese) 张守堂, 万国靖, 李璐.药物性肝损伤机制的研究进展[J].药学服务与研究, 2017, 17 (1) :39-42.
|
|
[3] CHEN CW. Research advances in drug-induced liver injury and existing problems in China[J]. J Clin Hepatol, 2018, 34 (6) :1147-1151. (in Chinese) 陈成伟.药物性肝损伤的研究进展及我国存在的问题[J].临床肝胆病杂志, 2018, 34 (6) :1147-1151.
|
|
[4] HAYASHI PH, FONTANA RJ. Clinical features, diagnosis, and natural history of drug-induced liver injury[J]. Seminars in Liver Disease, 2014, 34 (2) :134-144.
|
|
[5] LEI CJ, WU LP. Clinical types and biochemical indexes in patients with drug-induced liver failure[J/CD]. Chin J Liver Dis:Electr Version, 2018, 10 (1) :70-73. (in Chinese) 雷创杰, 吴柳萍.药物性肝衰竭患者的临床分型及生物化学指标的差异[J/CD].中国肝脏病杂志:电子版, 2018, 10 (1) :70-73.
|
|
[6] CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al. ACG Clinical Guideline:The diagnosis and management of idiosyncratic drug-induced liver injury.[J]. Am J Gastroenterol, 2014, 109 (7) :950-966.
|
|
[7] XU X, JI LS, LU LL, et al. Research advances in the pathogenesis of drug—induced liver injury[J]. J Clin Hepatol, 2016, 32 (2) :382-385. (in Chinese) 许新, 纪莉莎, 芦琳琳, 等.药物性肝损伤发病机制的研究进展[J].临床肝胆病杂志, 2016, 32 (2) :382-385.
|
|
[8] WANG HZ, LI XH. Research advances in the pathogenesis of drug-induced liver injury[J]. J Clin Hepatol, 2018, 34 (4) :883-887. (in Chinese) 王海珍, 李秀惠.药物性肝损伤发病机制研究进展[J].临床肝胆病杂志, 2018, 34 (4) :883-887.
|
|
[9] XU ZL, GAO M, GUO CX, et al. Clinical features of different types of drug-induced liver injury and their association with liver histological changes[J]. J Clin Hepatol, 2017, 33 (5) :924-927. (in Chinese) 徐曾丽, 高敏, 郭春霞, 等.药物性肝损伤临床分型特点及其与肝组织学改变的关系[J].临床肝胆病杂志, 2017, 33 (5) :924-927.
|
|
[10] DELEMOS AS, FOUREAU DM, JACOBS C, et al. Drug-induced liver injury with autoimmune features[J]. Semin Liver Dis, 2014, 34 (2) :194-204.
|
|
[11] LIU JS, ZHU LL, WANG GK, et al. Studies on chemical constituents from the fruit of swietenia macrophylla[J]. J Chin Med Materls, 2016, 39 (7) :1530-1535. (in Chinese) 刘劲松, 朱莉莉, 王国凯, 等.向天果化学成分研究[J].中药材, 2016, 39 (7) :1530-1535.
|
|
[12] SUN YP, ZHU LL, LIU JS, et al. Limonoids and triterpenoid from fruit of swietenia macrophylla[J]. Fitoterapia, 2018, 125:141-146.
|
|
[13] ZHANG QX, ZHANG JN, WANG WS, et al. Progress in pharmacological research to day fruit[C]. China Annual Conference on Laboratory Animal Science, 2017. (in Chinese) 张巧香, 张嘉宁, 王万山, 等.向天果药理活性研究进展[C].中国实验动物科学年会, 2017.
|
|
[14] ZHU LL, WANG GK, LIU JS, et al. Gas chromatographymass spectrometry analysis of fatty acids in fruit of Swietenia macrophylla[J]. J Anhui Univ Chin Med, 2014, 33 (3) :85-86. (in Chinese) 朱莉莉, 王国凯, 刘劲松, 等.向天果脂肪酸成分的气相色谱-质谱分析[J].安徽中医药大学学报, 2014, 33 (3) :85-86.
|
|
[15] MOGHADAMTOUSI SZ, GOH BH, CHAN CK, et al. Biological activities and phytochemicals of Swietenia macrophylla king[J]. Molecules, 2013, 18 (9) :10465-10483.
|
|
[16] KIPASSA NT, IWAGAWA T, OKAMURA H, et al. Limonoids from the stem bark of Cedrela odorata[J]. Phytochemistry, 2008, 69 (8) :1782-1787.
|
|
[17] ZHANG Y, XU H. Recent progress in the chemistry and biology of limonoids[J]. Rsc Advances, 2017, 7 (56) :35191-35220.
|
|
[18] MA YQ, LIU MH, JIANG K, et al. Limonoids from the fruits of Swietenia macrophylla with inhibitory activity against H2O2-induced apoptosis in HUVECs[J]. Fitoterapia, 2018, 129:179-184.
|
DownLoad: